APA (7th ed.) Citation

Weller, J. M., Schäfer, N., Schaub, C., Tzaridis, T., Zeyen, T., Schneider, M., . . . Seidel, C. (2023). Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial. Journal of neuro-oncology, 161(1), . https://doi.org/10.1007/s11060-022-04203-4

Chicago Style (17th ed.) Citation

Weller, Johannes Michael, et al. "Patterns, Predictors and Prognostic Relevance of High-grade Hematotoxicity After Temozolomide or Temozolomide-lomustine in the CeTeG/NOA-09 Trial." Journal of Neuro-oncology 161, no. 1 (2023). https://doi.org/10.1007/s11060-022-04203-4.

MLA (9th ed.) Citation

Weller, Johannes Michael, et al. "Patterns, Predictors and Prognostic Relevance of High-grade Hematotoxicity After Temozolomide or Temozolomide-lomustine in the CeTeG/NOA-09 Trial." Journal of Neuro-oncology, vol. 161, no. 1, 2023, https://doi.org/10.1007/s11060-022-04203-4.